Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AT&T

Stocks that pay steadily rising dividends tend to outperform stocks that don't. CVS Health's benefits management business is increasingly lucrative, because the company can directly provide more of the benefits it's paid to manage.

2 Unstoppable Dividend Growth Stocks to Buy for the Next Decade

Archer-Daniels-Midland Company

Johnson & Johnson

LyondellBasell Industries

United Parcel Service and Archer-Daniels-Midland are two dividend stocks to watch in June 2023. UPS has a dividend yield of 3.78%, while ADM offers a yield of 2.45% and has a 48-year history of growing dividends. Other dividend stocks to consider include CVS Pharmacy, LyondellBasell, and Johnson & Johnson.

Dividend Stock Watch List: Lanny's June 2023 Edition

Bank of America

Lululemon Athletica

Newmont Mining

NVIDIA

The first quarter of 2023 was quite eventful for investors, marked by several major bank collapses due to insufficient preparation for the rising interest rate environment and renewed fervor for artificial intelligence stocks following the rollout of OpenAI's ChatGPT. The S&P 500 climbed 7.45% for the quarter, while the Nasdaq soared 21.34% and the Dow Jones Industrial Average was mostly flat, up just 0.41%.

The Top Guru Stock Picks of the 1st Quarter

Allergan

Teva Pharmaceutical

Walgreens

Teva, Allergan, CVS and Walgreens said enough states agreed to final agreements, adding to the billions flowing to communities.

Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It

AbbVie

New York Attorney General Letitia James announced Friday the final approval of $17.3 billion in national settlement agreements with drug-store chains CVS Health Corp. CVS, and Walgreens Boots Alliance Inc. WBA, -0.68%, and with drug makers Teva Pharmaceutical Industries Ltd. TEVA, -0.61% and AbbVie Inc.'s ABBV, +0.61% Allergan.

NY AG approves $17.3 billion opioid settlement with CVS, Walgreens, Teva and AbbVie's Allergan

New career hub is part of company's commitment to extend accessible job training, placement to Detroit's overlooked pools of talent WOONSOCKET, R.I. , June 8, 2023 /PRNewswire/ -- In a demonstration of its ongoing commitment to address social determinants of health, such as employment and economic stability, CVS Health® (NYSE: CVS) today announced the opening of its newest Workforce Innovation and Talent Center (WITC) in collaboration with Goodwill Industries of Greater Detroit.

CVS Health opens new Workforce Innovation and Talent Center within Goodwill of Greater Detroit

CVS is delving into delivering primary care. It's already a major health insurer via its Aetna subsidiary.

3 Things About CVS Health That Smart Investors Know

CVS Health could have brighter days ahead with plans to sell an underperforming unit and its acquisitions of two new businesses. Walgreens' proximity to Americans' homes could help it win share in the primary care market.

Better Buy: CVS vs. Walgreens Stock

Citigroup

Caterpillar

Citizens & Northern

General Dynamics

Haleon PLC

Kinder Morgan

Norfolk Southern

Norwood Financial

Realty Income Corp

Healthpeak Properties

Premier Financial

Provident Financial Services

Procter & Gamble

Starbucks

Texas Instruments

Verizon

WestRock

The author's May dividend income reached $883, a 20.25% increase compared to May 2022. Banks contributed 22.4% of the May dividend income, with a total of $198.05. The AT&T dividend cut in 2021 still impacts the author's dividend income, preventing them from crossing the $1,000 mark.

Bert's May 2023 Dividend Income Summary

CVS has increased revenue for eight consecutive quarters. But lowered guidance has helped send the stock price down.

CVS Stock Just Hit a 52-Week Low. Is It Time to Buy?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

Why Is CVS Health (CVS) Up 0.1% Since Last Earnings Report?

American Electric Power Company

Amgen

Blackrock Inc

ConocoPhillips

Cisco Systems

Goldman Sachs

Coca-Cola

Medtronic

Morgan Stanley

Pfizer

PNC Financial Services

Phillips 66

Sempra Energy

Target

U.S. Bancorp

Vanguard High Dividend Yield ETF

There are 20 stocks on my high yield watchlist for June 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory. An equally weighted portfolio of these stocks underperformed the Vanguard High Yield Dividend ETF by about 1.5% during the month of May.

High Yield Stock Watchlist: June 2023

Now that Johnson & Johnson has spun off its slow-moving consumer health division, its pharmaceutical and medical technology segments are expected to drive growth at a faster pace than usual. Medtronic is purely a medical device company with a slate of new product launches that could drive dividend growth in the years to come.

3 Reliable Dividend Growth Stocks to Buy Hand Over Fist in June

CVS Health Corporation (NYSE:CVS ) Bernstein's 39th Annual Strategic Decisions Conference May 31, 2023 9:00 AM ET Company Participants Shawn M. Guertin - EVP and Chief Financial Officer Conference Call Participants Lance Wilkes - Bernstein Lance Wilkes Okay, looks like we are ready to go and mike is on and everything like that.

CVS Health Corporation (CVS) Bernstein's 39th Annual Strategic Decisions Conference

DENVER--(BUSINESS WIRE)--Strive Health, a national leader in value-based kidney care, has raised $166 million in Series C funding. This funding round was led by NEA alongside five new investors, including large strategic investor CVS Health Ventures. Additional investments from all previous strategic investors – CapitalG (Alphabet), Echo Ventures, Town Hall Ventures, Ascension Ventures and Redpoint – completed the round. This comes at a critical time for the 37 million U.S. adults living with c.

Strive Health Raises $166 Million in Series C Funding from NEA, CVS Health Ventures and Others

CVS Health Corp. stock CVS is up fractionally in premarket trades Wednesday after the company said it plans to reiterate its financial targets for 2023 ahead of an investor meeting. CVS said it continues to expect adjusted 2023 profit of $8.50 to $8.70 a share, compared to the FactSet data estimate of $8.62 a share.

CVS reiterates profit estimates for 2023

Allstate

While the concept of heavily bidding up blue-chip stocks for a healthy portfolio isn't exactly the most exciting proposition, under the present circumstances, it could be the most sensible. Fundamentally, with Democrats and Republicans at loggerheads over the debt ceiling crisis, anything can happen.

3 Blue-Chip Stocks to Buy for a Healthy and Wealthy Portfolio

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields - CVS Health (NYSE:CVS), AbbVie (NYSE:ABBV)

AllianceBernstein Hld

Arbor Realty Trust

American Tower

Ares Capital

Alexandria Real Estate Equities

BHP Billiton

British American Tobacco

Fifth Third Bancorp

March-April, 2022, UBS, Kiplinger, and Barron's analysts/reporters listed five-sets of stocks sorted=as: “Inflation-Busters.” Those five articles revealed 47 equities, with 42 paying dividends. This over one-year-old list continues to beat-back rampant inflation.

Of 11 Ideal Inflation-Busting May Dividend Dogs, Buy 3

News for CVS Health Stock (CVS)